A detailed history of Wellington Management Group LLP transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 171,764 shares of EYPT stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
171,764
Previous 107,756 59.4%
Holding current value
$1.58 Million
Previous $937,000 46.42%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.58 - $10.54 $485,180 - $674,644
64,008 Added 59.4%
171,764 $1.37 Million
Q2 2024

Aug 13, 2024

BUY
$8.16 - $22.89 $879,288 - $2.47 Million
107,756 New
107,756 $937,000

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $312M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.